ENLIVEN THERAPEUTICS, INC. (ELVN) /
The profitability of ENLIVEN THERAPEUTICS, INC. over the past 7 years
Chart ENLIVEN THERAPEUTICS, INC.: operating income, net income, fiscal 2019–2025 Open the chart →ENLIVEN THERAPEUTICS, INC. reported a net loss of $103.69M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $119.66M. It reported a loss in all 7 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$119.66M | -$103.69M |
| 2024ended Dec 31, 2024 | -$104.55M | -$89.02M |
| 2023ended Dec 31, 2023 | -$83.53M | -$71.58M |
| 2022ended Dec 31, 2022 | -$38.79M | -$37.66M |
| 2021ended Dec 31, 2021 | -$51.44M | -$51.38M |
| 2020ended Dec 31, 2020 | -$41.7M | -$41.36M |
| 2019ended Dec 31, 2019 | -$24.12M | -$23.46M |
Fiscal years as ENLIVEN THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ENLIVEN THERAPEUTICS, INC.
- The cash flow of ENLIVEN THERAPEUTICS, INC.
- The debt of ENLIVEN THERAPEUTICS, INC.
- All of ENLIVEN THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- NBTBNBT BANCORP INC
- LGNLegence Corp.
- REZIResideo Technologies, Inc.
- BCCBoise Cascade Company
- HWKNHAWKINS, INC.
Not investment advice. This page shows what ENLIVEN THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.